quinazolines has been researched along with Black Fever in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Ankur, V; Kumar, SP; Kumar, SS; Mahender, T; Pankaj, W | 1 |
Dujardin, JC; Kyle, DE; Manetsch, R; Pandharkar, T; Rijal, S; Van Horn, KS; Vanaerschot, M; Vesely, B; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X | 1 |
Barber, MM; Manetsch, R; Van Horn, KS; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X | 1 |
Ali, N; Bhattacharyya, A; Chhajer, R; Das, N; Didwania, N; Palit, P; Shadab, M; Vaidya, T | 1 |
Feiz Barazandeh, A; Jia, P; Keynan, Y; Khadem, F; Liu, D; Mou, Z; Uzonna, JE | 1 |
1 review(s) available for quinazolines and Black Fever
Article | Year |
---|---|
Some Scaffolds as Anti-leishmanial Agents: A Review.
Topics: Antiprotozoal Agents; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Quinazolines | 2022 |
4 other study(ies) available for quinazolines and Black Fever
Article | Year |
---|---|
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
Topics: Animals; Antimony; Cell Line; Diamines; Drug Resistance; Leishmania; Leishmania donovani; Leishmania mexicana; Leishmaniasis, Visceral; Macrophages; Male; Mice, Inbred BALB C; Quinazolines; Structure-Activity Relationship; Trypanocidal Agents | 2014 |
SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
Topics: Animals; Antiprotozoal Agents; Diamines; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Neglected Diseases; Quinazolines; Structure-Activity Relationship | 2015 |
Leishmania donovani Aurora kinase: A promising therapeutic target against visceral leishmaniasis.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Aurora Kinases; Aza Compounds; Catalytic Domain; Cell Cycle; Cell Survival; Cytokinesis; Female; Indoles; Kinetics; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Organophosphates; Protein Kinase Inhibitors; Quinazolines; Sulfonamides | 2016 |
Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
Topics: Adenine; Amphotericin B; Animals; CD4 Lymphocyte Count; Class I Phosphatidylinositol 3-Kinases; Cytokines; Drug Therapy, Combination; Female; Immunomodulation; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Lymph Nodes; Mice; Mice, Inbred BALB C; Parasite Load; Phosphoinositide-3 Kinase Inhibitors; Purines; Quinazolines; Quinazolinones; Spleen; T-Lymphocytes, Regulatory | 2017 |